IMPROVING THE PROGNOSTIC VALUE OF DNA FLOW-CYTOMETRY IN METASTATIC MELANOMA BY COMBINING PLOIDY AND S-PHASE FRACTION

被引:2
|
作者
MUHONEN, T
机构
[1] Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Helsinki, SF-00290
关键词
DNA; FLOW CYTOMETRY; MELANOMA; MELANOMA MORTALITY; PLOIDY; S-PHASE FRACTION;
D O I
10.1097/00008390-199211000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic value of cellular DNA content of melanoma metastases was investigated in tumours from 114 consecutive patients referred to the Helsinki University Central Hospital Melanoma Team. Thirty-six percent of the tumours were diploid and 64% aneuploid. For 91 patients the S-phase fraction was calculable. Tumour ploidy and S-phase fraction (SPF) were shown by multivariate Cox model analysis to be independent prognostic variables and major determinants of survival after first recurrence. Patients with either aneuploid or low SPF tumours survived longer than did those with diploid or high SPF tumours. By combining DNA ploidy and SPF, three types of DNA histograms could be defined, associated with favourable, intermediate and poor prognosis. Patients with aneuploid, low SPF metastases showed a median survival of 57 months, whereas the high-risk group with diploid, high SPF metastases survived only 13 months. When ploidy, SPF, age, sex, TNM stage and duration of disease-free survival were analysed as covariates the division of flow cytometry histograms into these three types resulted in the most significant prognostic factor (p<0.001) in the Cox multivariate analysis.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [21] DNA-PLOIDY AND S-PHASE FRACTION AS PROGNOSTIC FACTORS IN PATIENTS WITH UVEAL MELANOMAS
    KARLSSON, M
    BOERYD, B
    CARSTENSEN, J
    KAGEDAL, B
    WINGREN, S
    BRITISH JOURNAL OF CANCER, 1995, 71 (01) : 177 - 181
  • [22] Flow cytometry in primary breast carcinomas: Prognostic impact of S-phase fraction according to different analysis patterns
    Michels, JJ
    Marnay, J
    Plancoulaine, B
    Chasle, J
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2004, 59B (01): : 32 - 39
  • [23] The prognostic value of S-phase fraction in preoperative radiotherapy of rectal cancer
    Lammering, G
    Taher, MM
    Borchard, F
    Gruenagel, HH
    Porschen, R
    ONCOLOGY REPORTS, 2001, 8 (01) : 201 - 206
  • [24] DNA PLOIDY, S-PHASE FRACTION AND G2 FRACTION AS PROGNOSTIC DETERMINANTS IN PROSTATIC ADENOCARCINOMA
    ESKELINEN, M
    LIPPONEN, P
    MAJAPURO, R
    SYRJANEN, K
    NORDLING, S
    EUROPEAN UROLOGY, 1991, 20 (01) : 62 - 66
  • [25] PROGNOSTIC VALUE OF ANALYSIS OF DNA IN PANCREATIC ADENOCARCINOMA BY FLOW-CYTOMETRY
    HYOTY, M
    VISAKORPI, T
    KALLIONIEMI, OP
    MATTILA, J
    LAIPPALA, P
    NORDBACK, I
    ACTA CHIRURGICA-THE EUROPEAN JOURNAL OF SURGERY, 1991, 157 (10): : 595 - 600
  • [26] Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer
    Victorzon, M
    Roberts, PJ
    Haglund, C
    VonBoguslawsky, K
    Nordling, S
    ANTICANCER RESEARCH, 1997, 17 (4B) : 2923 - 2926
  • [27] Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer
    Lundin, J
    Nordling, S
    VonBoguslawsky, K
    Roberts, PJ
    Haglund, C
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2659 - 2668
  • [28] Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma
    Wilailak, S
    Rochanawutanon, M
    Srisupundit, S
    Aumkhyan, A
    Pattanapanyasat, K
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (04) : 428 - 430
  • [29] Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma
    Pinto, AE
    Chaves, P
    Fidalgo, P
    Oliveira, AG
    Leitao, CN
    Soares, J
    DISEASES OF THE COLON & RECTUM, 1997, 40 (04) : 411 - 419
  • [30] PROGNOSTIC POTENTIAL OF FLOW CYTOMETRIC S-PHASE AND PLOIDY PROSPECTIVELY DETERMINED IN PRIMARY BREAST CARCINOMAS
    EWERS, SB
    ATTEWELL, R
    BALDETORP, B
    BORG, A
    LANGSTROM, E
    KILLANDER, D
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 20 (02) : 93 - 108